Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gout Flares and Mortality After Sodium-Glucose Cotransporter-2 Inhibitor Treatment for Gout and Type 2 Diabetes
Jie Wei, Hyon K. Choi, Nicola Dalbeth, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2330885-e2330885
Open Access | Times Cited: 25

Showing 25 citing articles:

Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 35
The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout
Chio Yokose, Natalie McCormick, Abhishek Abhishek, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 216-231
Closed Access | Times Cited: 14
Controversies and practical management of patients with gout and chronic kidney disease
Richard J. Johnson, Brian F. Mandell, Naomi Schlesinger, et al.
Kidney International (2024) Vol. 106, Iss. 4, pp. 573-582
Closed Access | Times Cited: 13
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Samuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1099-1124
Open Access | Times Cited: 10
Reducing hyperuricemic events with SGLT2 inhibitors: An updated systematic review with meta-regression
Hamlet Ghukasyan, Denilsa Navalha, Ignacio Pérez Romero, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2025) Vol. 72, Iss. 1, pp. 26-36
Closed Access | Times Cited: 1
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies
Natalie McCormick, Chio Yokose, Na Lu, et al.
BMJ (2024), pp. e080035-e080035
Open Access | Times Cited: 6
Gout and its management
Nicola Dalbeth, Leanne Te Karu, Lisa K. Stamp
Internal Medicine Journal (2024) Vol. 54, Iss. 5, pp. 716-723
Open Access | Times Cited: 4
Dual benefits of sodium-glucose cotransporter 2 inhibitors in metabolic diseases: Diabetes control and gout management
Xiao-Peng Fu
World Journal of Clinical Cases (2025) Vol. 13, Iss. 14
Closed Access
New Medications for Diabetes Care
Satish K. Garg, D. Renner, Amanda Rewers, et al.
Diabetes Technology & Therapeutics (2025) Vol. 27, Iss. S1, pp. S208-S219
Closed Access
SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum
Frank Preston, Matthew Anson, David R. Riley, et al.
Clinical Therapeutics (2024)
Open Access | Times Cited: 3
Newer Glucose-Lowering Drugs and Risk of Gout: A Network Meta-Analysis of Randomized Outcomes Trials
Aihua Wang, Weilong Shi, Ning Zhang, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 11, pp. 851-854
Closed Access | Times Cited: 2
Emerging therapeutic options for refractory gout
Kanon Jatuworapruk, Worawit Louthrenoo
Nature Reviews Rheumatology (2023) Vol. 20, Iss. 2, pp. 73-74
Closed Access | Times Cited: 5
Gout risk in adults with pre-diabetes initiating metformin
Javier Marrugo, L Santacroce, Misti L. Paudel, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 10, pp. 1368-1374
Open Access | Times Cited: 1
SGLT2 Inhibitors and Uric Acid Homeostasis
Ava M. Zapf, Owen M. Woodward
Gout Urate and Crystal Deposition Disease (2024) Vol. 2, Iss. 2, pp. 157-172
Open Access | Times Cited: 1
SGLT2 Inhibitors and Their Effect on Urolithiasis: Current Evidence and Future Directions
Živka Dika, Marijana Živko, Marina Kljajić, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 6017-6017
Open Access | Times Cited: 1
Get on top of gout with a fresh look at treatment options
Caroline Fenton, Connie Kang
Drugs & Therapy Perspectives (2024) Vol. 40, Iss. 3, pp. 115-120
Closed Access
Investigating gout flares: beyond a definition
Charles Sutherland, Angelo Gaffo
Current Opinion in Rheumatology (2024)
Closed Access
SGLT-2 inhibitors: Diabetes and CKD and CHF (and gout?), oh my!
Brian F. Mandell
Cleveland Clinic Journal of Medicine (2024) Vol. 91, Iss. 7, pp. 392-393
Open Access
Rhumatismes microcristallins
Charlotte Jauffret
Revue du Rhumatisme (2024) Vol. 91, Iss. 5, pp. 570-572
Closed Access
Diabetes and gout: another role for SGLT2 inhibitors?
Clifford J. Bailey
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access
Reducing hyperuricemic events with SGLT2 inhibitors: An updated systematic review with meta-regression
Hamlet Ghukasyan, Denilsa Navalha, Ignacio Pérez Romero, et al.
Endocrinología Diabetes y Nutrición (2024)
Closed Access
The cellular and molecular mechanisms mediating the protective effects of sodium–glucose linked transporter 2 inhibitors against metabolic dysfunction‐associated fatty liver disease
Na Ao, Jian Du, Shi Jin, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 457-467
Closed Access
Year in Review 2023: Gout Clinical Research
Gregory J. Challener, Chio Yokose
Gout Urate and Crystal Deposition Disease (2024) Vol. 2, Iss. 4, pp. 354-369
Open Access
A Systematic Review and Meta-Analysis of Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors and Their Impact on the Management of Heart Failure
Nestor Lemos Ferreira, Abiodun Bamidele Adelowo, Zahid Khan
Cureus (2024)
Open Access
Contemporary prospects for the use of sodium-glucose cotransporter-2 inhibitors
Anastasia R. Kondratieva, E. A. Khazova, Alina Vadimovna Lobanova, et al.
Perm Medical Journal (2024) Vol. 41, Iss. 6, pp. 92-108
Open Access
Page 1

Scroll to top